Skip to main content

McKesson Value Stock - Dividend - Research Selection

McKesson

ISIN: US58155Q1031, WKN: 893953

Market price date: 28.05.2020
Market price: 156,86 USD




McKesson Fundamental data and company key figures of the share

Annual reports in USD
Key figures 24-05-2020
Cash flow
Net operating cash flow 4.374.000.000
Capital Expenditures -506.000.000
Free cash flow 3.868.000.000
Balance sheet
Total Equity 5.092.000.000
Liabilities & Shareholders equity 61.247.000.000
Income statement
Net income 900.000.000
Eps (diluted) 4,950
Diluted shares outstanding 181.818.000
Net sales/revenue 224.945.000.000

Fundamental ratios calculated on: 28-05-2020

Ratios
Key figures 28-05-2020
Cash flow
P/C 6,52
   
P/FC 7,37
Balance sheet
ROI1,47
ROE8,31
Income statement
P/E31,69
Div. Yield1,03%
P/B5,60
P/S0,13


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolMCK
Market Capitalization28.243.607.552,00 USD
CountryUnited States
IndicesS&P 500
SectorsHealth service
Raw Data SourceUS GAAP in Millionen USD
Stock Split1998-01-05,2.0000/1.0000
Internetwww.mckesson.com


Description of the company

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, this segment operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks in North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. This segment serves retail national accounts, including national and regional chains, food/drug combinations, mail order pharmacies, and mass merchandisers; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as offers its services to pharmaceutical manufacturers. The McKesson Technology Solutions segment provides clinical, financial, and supply chain management solutions to healthcare organizations. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.mckesson.com